CognifiSense is a Silicon Valley-based startup developing virtual reality (VR) pain management technologies. Our core product, VR Neuropsychological Therapy or VRNT is a proprietary technology aimed at creating a lasting reduction in chronic pain. We combine psychological therapies with the immersive power of VR to address the maladaptive neuroplastic changes in the brain that drive chronic pain.
Chronic pain affects 100 million in the United States and ~1.5 billion people globally. Traditional pain drugs and devices only mitigate the symptoms of pain and do not address the underlying causes of chronic pain.
Immersive video games that shift the user's focus from the pain are known as "distraction therapy". VRNT differs from distraction therapy in that it specifically targets the brain's "neuroplasticity", or ability to change over time.